Drug Type Monoclonal antibody |
Synonyms ND 3014, ND-3014, ND3014 |
Target |
Mechanism TDP43 inhibitors(TAR DNA binding protein 43 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | SE | 16 Nov 2021 |